Aggregator
Exploiting the mechanical effects of ultrasound for noninvasive therapy
Science, Volume 385, Issue 6714, September 2024.
Durably reducing conspiracy beliefs through dialogues with AI
Science, Volume 385, Issue 6714, September 2024.
Autoregulated splicing of TRA2β programs T cell fate in response to antigen-receptor stimulation
Science, Volume 385, Issue 6714, September 2024.
Microbial dietary preference and interactions affect the export of lipids to the deep ocean
Science, Volume 385, Issue 6714, September 2024.
Transcripts of repetitive DNA elements signal to block phagocytosis of hematopoietic stem cells
Science, Volume 385, Issue 6714, September 2024.
Daily briefing: Why we choke under pressure
Academics say flying to meetings harms the climate — but they carry on
Plagued by mosquitoes? Try some bite-blocking fabrics
Bill targeting Chinese biotechs worries U.S. researchers
Biosecure Act could hinder science collaborations, limit sequencer purchases
Live from the ‘Iggies’: Eight things you didn’t know about science’s wackiest night
At the Ig Nobel Prize ceremony, tradition and humor take center stage
Final U.S. misconduct rule drops controversial changes
Biomedical oversight agency replaces proposal to publicize institutional findings with smaller steps toward greater transparency
Midnolin, a Genetic Risk Factor for Parkinson's Disease, Promotes Neurite Outgrowth Accompanied by Early Growth Response 1 Activation in PC12 Cells
Parkinson's disease (PD) is an age-related progressive neurodegenerative disease. Previously, we identified midnolin (MIDN) as a genetic risk factor for PD. Although MIDN copy number loss increases the risk of PD, the molecular function of MIDN remains unclear. To investigate the role of MIDN in PD, we established monoclonal Midn knockout (KO) PC12 cell models. Midn KO inhibited neurite outgrowth and neurofilament light chain (Nefl) gene expression. Although MIDN is mainly localized in the...
Altered firing output of VIP interneurons and early dysfunctions in CA1 hippocampal circuits in the 3xTg mouse model of Alzheimer's disease
Alzheimer's disease (AD) leads to progressive memory decline, and alterations in hippocampal function are among the earliest pathological features observed in human and animal studies. GABAergic interneurons (INs) within the hippocampus coordinate network activity, among which type 3 interneuron-specific (I-S3) cells expressing vasoactive intestinal polypeptide and calretinin play a crucial role. These cells provide primarily disinhibition to principal excitatory cells (PCs) in the hippocampal...
Remember oligodendrocytes: Uncovering their overlooked role in Alzheimer's disease
Our understanding of Alzheimer's disease (AD) has evolved from focusing solely on neurons to recognizing the role of glia. A recent study in PLOS Biology revealed that oligodendrocytes are an important source of Aβ that impairs neuronal function.
The burden of a gene
A variant called APOE4 is notorious for its link to Alzheimer's. Can new insights into its function help stave off disease?
Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics
The development of successful therapeutics for dementias requires an understanding of their shared and distinct molecular features in the human brain. We performed single-nuclear RNA-seq and ATAC-seq in Alzheimer's disease (AD), frontotemporal dementia (FTD), and progressive supranuclear palsy (PSP), analyzing 41 participants and ∼1 million cells (RNA + ATAC) from three brain regions varying in vulnerability and pathological burden. We identify 32 shared, disease-associated cell types and 14...
Phosphorylation of tau at a single residue inhibits binding to the E3 ubiquitin ligase, CHIP
Microtubule-associated protein tau (MAPT/tau) accumulates in a family of neurodegenerative diseases, including Alzheimer's disease (AD). In disease, tau is aberrantly modified by post-translational modifications (PTMs), including hyper-phosphorylation. However, it is often unclear which of these PTMs contribute to tau's accumulation or what mechanisms might be involved. To explore these questions, we focus on a cleaved proteoform of tau (tauC3), which selectively accumulates in AD and was...
Clearance and transport of amyloid beta by peripheral monocytes correlate with Alzheimer's disease progression
Impaired clearance of amyloid β (Aβ) in late-onset Alzheimer's disease (AD) affects disease progression. The role of peripheral monocytes in Aβ clearance from the central nervous system (CNS) is unclear. We use a flow cytometry assay to identify Aβ-binding monocytes in blood, validated by confocal microscopy, Western blotting, and mass spectrometry. Flow cytometry immunophenotyping and correlation with AD biomarkers are studied in 150 participants from the AIBL study. We also examine monocytes...
Aged bone marrow macrophages drive systemic aging and age-related dysfunction via extracellular vesicle-mediated induction of paracrine senescence
Post-2030 global goals need explicit targets for cities and businesses
Science, Volume 385, Issue 6714, September 2024.